Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
59
USM Quote, Financials, Valuation and Earnings
Last price:
$62.14
Seasonality move
:
-0.28%
Day range:
$61.15 - $62.79
52-week range:
$32.01 - $68.31
Dividend yield:
0%
P/E ratio:
63.57x
P/S ratio:
1.44x
P/B ratio:
1.17x
Volume:
166.5K
Avg. volume:
129.5K
1-year change:
54.02%
Market cap:
$5.3B
Revenue:
$3.9B
EPS (TTM):
-$0.36
Earnings Data
Next earnings date for USM
Feb 14
2025
Most recent earnings per share
-$0.92
Missed by $2.19
(Nov 1/2024)
Consensus Estimate
$1.27
(Nov 1/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
USM Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/14/2025 | Q4 | $964.7M | -- | -- | $1.70 | -- |
| 11/01/2024 | Q3 | $940.9M | $922M | -$0.92 | $1.27 | -$2.19 |
| 08/02/2024 | Q2 | $933.1M | $927M | $0.20 | $1.25 | -$1.05 |
| 05/03/2024 | Q1 | $958.2M | $950M | $0.20 | $1.10 | -$0.90 |
| 02/16/2024 | Q4 | $985M | $1B | $0.16 | $0.95 | -$0.79 |
| 11/03/2023 | Q3 | -- | -- | $0.26 | $0.06 | $0.20 |
| 08/04/2023 | Q2 | -- | -- | $0.05 | $0.20 | -$0.15 |
| 05/04/2023 | Q1 | -- | -- | $0.15 | $0.34 | -$0.19 |
| 02/16/2023 | Q4 | -- | -- | -$0.33 | -$0.34 | $0.01 |
| 11/03/2022 | Q3 | -- | -- | -$0.15 | $0.25 | -$0.40 |
| 08/04/2022 | Q2 | -- | -- | $0.25 | $0.31 | -$0.06 |
| 05/05/2022 | Q1 | -- | -- | $0.57 | $0.48 | $0.09 |
| 02/17/2022 | Q4 | -- | -- | $0.31 | $0.17 | $0.14 |
| 11/04/2021 | Q3 | -- | -- | $0.38 | $0.42 | -$0.04 |
| 08/05/2021 | Q2 | -- | -- | $0.39 | $0.43 | -$0.04 |
| 05/06/2021 | Q1 | -- | -- | $0.69 | $0.63 | $0.06 |
| 02/18/2021 | Q4 | -- | -- | $0.06 | $0.05 | $0.01 |
| 11/05/2020 | Q3 | -- | -- | $0.97 | $0.27 | $0.70 |
| 08/06/2020 | Q2 | -- | -- | $0.78 | $0.22 | $0.56 |
| 04/30/2020 | Q1 | -- | -- | $0.81 | $0.55 | $0.26 |
| 02/20/2020 | Q4 | -- | -- | $0.20 | $0.02 | $0.18 |
| 10/31/2019 | Q3 | -- | -- | $0.27 | $0.36 | -$0.09 |
| 08/01/2019 | Q2 | -- | -- | $0.35 | $0.44 | -$0.09 |
| 05/02/2019 | Q1 | -- | -- | $0.62 | $0.50 | $0.12 |
| 02/22/2019 | Q4 | -- | -- | $0.23 | $0.33 | -$0.10 |
| 11/02/2018 | Q3 | -- | -- | $0.41 | $0.28 | $0.13 |
| 08/03/2018 | Q2 | -- | -- | $0.56 | -- | -- |
| 05/01/2018 | Q1 | -- | -- | $0.52 | -- | -- |
| 02/23/2018 | Q4 | -- | -- | $3.18 | -- | -- |
| 11/08/2017 | Q3 | -- | -- | -$3.51 | -- | -- |
| 08/04/2017 | Q2 | -- | -- | $0.14 | -- | -- |
| 05/05/2017 | Q1 | -- | -- | $0.31 | -- | -- |
| 02/24/2017 | Q4 | -- | -- | -$0.07 | -- | -- |
| 11/04/2016 | Q3 | -- | -- | $0.20 | -- | -- |
| 08/05/2016 | Q2 | -- | -- | $0.32 | -- | -- |
| 05/06/2016 | Q1 | -- | -- | $0.10 | -- | -- |
| 02/19/2016 | Q4 | -- | -- | -$0.02 | -- | -- |
| 10/30/2015 | Q3 | -- | -- | $0.75 | -- | -- |
| 07/31/2015 | Q2 | -- | -- | $0.23 | -- | -- |
| 05/01/2015 | Q1 | -- | -- | $1.89 | -- | -- |
| 02/25/2015 | Q4 | -- | -- | -$0.25 | -- | -- |
United States Cellular Earnings Questions
-
How Much did United States Cellular Generate in Revenue Last Quarter?
United States Cellular reported $922M worth of top line sales in its most recent quarter.
-
Did United States Cellular Beat Earnings Last Quarter?
United States Cellular announced earnings per share of -$0.92 which represents a miss of analyst forecast a $1.27 per share.
-
Is United States Cellular Profitable?
United States Cellular reported $539M that represents $6.27 per share over the last quarter.
-
What is the Analyst Consensus for United States Cellular EPS Next Year?
United States Cellular's earnings are forecast to grow from $0.63 per share to $4.41 per share next year representing an increase of 711.11%.
-
When is United States Cellular's Earnings Date?
United States Cellular's next earnings date is February 14, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
